2026年福泰制药历年年报/社会责任报告/ESG报告合集（共37套打包）

1、Vertex Reports Third Quarter 2025 Financial ResultsNovember 3,2025 Total revenue of$3.08 billion,an 11%increase compared to Q3 2024 Refined full year financial guidance:total revenue guidance now$11.。

2、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934FOR THE QUARTERLY 。

3、2025 Vertex Pharmaceuticals Incorporated 2025 Vertex Pharmaceuticals Incorporated FIRST QUARTER 2025 FINANCIAL RESULTS2025 Vertex Pharmaceuticals IncorporatedThird Quarter 2025Financial ResultsNovemb。

4、Vertex Reports Second Quarter 2025 Financial ResultsAugust 4,2025 Total revenue of$2.96 billion,a 12%increase compared to Q2 2024;reiterated full year 2025 financial guidance,including revenue guidan。

5、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934FOR THE QUARTERLY 。

6、2025 Vertex Pharmaceuticals Incorporated 2025 Vertex Pharmaceuticals Incorporated FIRST QUARTER 2025 FINANCIAL RESULTS2025 Vertex Pharmaceuticals IncorporatedSecond Quarter 2025Financial ResultsAugus。

7、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

8、Vertex Reports First Quarter 2025 Financial ResultsMay 5,2025 Total revenue of$2.77 billion,a 3%increase compared to Q1 2024;raised the low end of total revenue guidance by$100 million to a new range。

9、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934FOR THE QUARTERLY 。

10、2025 Vertex Pharmaceuticals Incorporated 2025 Vertex Pharmaceuticals Incorporated FIRST QUARTER 2025 FINANCIAL RESULTS2025 Vertex Pharmaceuticals IncorporatedFirst Quarter 2025Financial ResultsMay 5,。

11、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

12、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

13、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

14、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

15、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,2。

16、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-KxANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31,。

17、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-Kx ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the Fiscal Year Ended December 31。

18、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/23/17 for the Period Ending 12/31/16 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharm。

19、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/16/16 for the Period Ending 12/31/15 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharm。

20、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/13/15 for the Period Ending 12/31/14 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharm。

21、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/11/14 for the Period Ending 12/31/13 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharm。

22、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 03/01/13 for the Period Ending 12/31/12 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6173416100CIK0000875320SymbolVRTXSIC Code28。

23、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/22/12 for the Period Ending 12/31/11 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code28。

24、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/17/11 for the Period Ending 12/31/10 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code28。

25、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/19/10 for the Period Ending 12/31/09 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code28。

26、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/17/09 for the Period Ending 12/31/08 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code28。

27、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/11/08 for the Period Ending 12/31/07 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6165776000CIK0000875320SymbolVRTXSIC Code28。

28、FORM 10-K VERTEX PHARMACEUTICALS INC/MA(Annual Report)Filed 3/1/2007 For Period Ending 12/31/2006Address130 WAVERLY STREETCAMBRIDGE,Massachusetts 02139-4242Telephone616-577-6000 CIK0000875320Industry。

29、FORM 10-K VERTEX PHARMACEUTICALS INC/MA(Annual Report)Filed 3/16/2006 For Period Ending 12/31/2005Address130 WAVERLY STREETCAMBRIDGE,Massachusetts 02139-4242Telephone616-577-6000 CIK0000875320Industr。

30、FORM 10-K VERTEX PHARMACEUTICALS INC/MA(Annual Report)Filed 3/15/2004 For Period Ending 12/31/2003Address130 WAVERLY STREETCAMBRIDGE,Massachusetts 02139-4242Telephone616-577-6000 CIK0000875320Industr。

31、 Use these links to rapidly review the document FORM 10-K INDEX VERTEX PHARMACEUTICALS INCORPORATED Index to Consolidated Financial Statements 2003.EDGAR Online,Inc.UNITED STATES SECURITIES AND EXCHA。

32、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31,2001 COMMI。

33、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31,2000 COMMI。

34、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K(MARK ONE)/X/ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 3。

35、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K(Mark One)X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES-EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31。

36、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K(Mark One)/X/ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 3。

37、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K(Mark One)X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE-ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31。